Cannabis Finds Its Way into Treatment of Crohn’s Disease.

Posted on December 21, 2013 by David

“In ancient medicine, cannabis has been widely used to cure disturbances and inflammation of the bowel. A recent clinical study now shows that the medicinal plant Cannabis sativa has lived up to expectations and proved to be highly efficient in cases of inflammatory bowel diseases.

In a prospective placebo-controlled study, it has been shown what has been largely anticipated from anecdotal reports, i.e. that cannabis produces significant clinical benefits in patients with Crohn’s disease. The mechanisms involved are not yet clear but most likely include peripheral actions on cannabinoid receptors 1 and 2, and may also include central actions.”

http://www.ncbi.nlm.nih.gov/pubmed/24356243

“In their prospective study, Naftali et al. used THC-free Cannabis as placebo with no other cannabinoids present. However, we should consider that also other ingredients of Cannabis, such as cannabidiol, cannabigerol, and tetrahydrocannabivarine (THCV), all of them non-psychotropic components of Cannabis, have proven antiinflammatory effects in experimental intestinal inflammation. Their actions partly involve non-CB receptor mechanisms via, for instance, peroxisome proliferator-activated receptors (PPAR) and transient receptor potential cation channels subfamily V receptors (TRPV) and should be regarded as additive beneficial effects of Cannabis in the improvement of colitis in addition to THC-mediated effects.

…an 8-week treatment with THC-rich Cannabis caused a decrease of the Crohn’s disease activity index (CDAI) in 90% of patients without producing significant side effects…

In summary, in agreement with the ancient use of Cannabis in intestinal disturbances and one decade of animal research, Cannabis was shown in a clinical trial to reduce symptoms in patients with CD. This elegant translation should be followed by larger trials confirming these results and by trials establishing the involved mechanisms to open a promising direction for future treatment of IBD.”

Full-text: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076530/

Therapeutic potential of cannabinoid medicines.

Posted on September 6, 2013 by David

Drug Testing and Analysis

“Cannabis was extensively used as a medicine throughout the developed world in the nineteenth century but went into decline early in the twentieth century ahead of its emergence as the most widely used illicit recreational drug later that century. Recent advances in cannabinoid pharmacology alongside the discovery of the endocannabinoid system (ECS) have re-ignited interest in cannabis-based medicines.

The ECS has emerged as an important physiological system and plausible target for new medicines. Its receptors and endogenous ligands play a vital modulatory role in diverse functions including immune response, food intake, cognition, emotion, perception, behavioural reinforcement, motor co-ordination, body temperature, wake/sleep cycle, bone formation and resorption, and various aspects of hormonal control. In disease it may act as part of the physiological response or as a component of the underlying pathology.

In the forefront of clinical research are the cannabinoids delta-9-tetrahydrocannabinol and cannabidiol, and their contrasting pharmacology will be briefly outlined. The therapeutic potential and possible risks of drugs that inhibit the ECS will also be considered. This paper will then go on to review clinical research exploring the potential of cannabinoid medicines in the following indications: symptomatic relief in multiple sclerosis, chronic neuropathic pain, intractable nausea and vomiting, loss of appetite and weight in the context of cancer or AIDS, psychosis, epilepsy, addiction, and metabolic disorders.”

http://www.ncbi.nlm.nih.gov/pubmed/24006213

http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/abstract

Medical Marijuana Achieves ‘Complete Remission’ Of Crohn’s Disease; Drug Improves Appetite And Sleep Function, With No Side Effects

Posted on July 24, 2013 by David

“Smoking medical marijuana achieved remission in five of 11 subjects with Crohn’s disease who smoked twice a day for eight weeks, as part of a study.”

Crohn’s disease, one of several inflammatory bowel diseases, achieved “complete remission” in nearly half the subjects of one study that were exposed to smoking medical marijuana on a regular basis.

Published in the journal Clinical Gastroenterology and Hepatology, the study examined the effects of consistent marijuana use on Crohn’s patients who suffered from severe cases of the disease. The results of the 21-subject study point toward the drug’s anti-inflammatory properties as being responsible for quieting symptoms in many patients, and even reaching total remission in others.”

More: http://www.medicaldaily.com/articles/17529/20130718/medical-marijuana-crohns-disease-remission-anti-inflammatory-drug-inflammatory-bowel-disease.htm

“Study: Marijuana May Achieve Complete Remission of Crohn’s Disease” http://blog.mpp.org/research/study-marijuana-may-achieve-complete-remission-of-crohns-disease/07192013/

“Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study... The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases… We performed a prospective trial to determine whether cannabis can induce remission in patients with Crohn’s disease…Complete remission was achieved by 5/11 subjects in the cannabis group…Three patients in the cannabis group were weaned from steroid dependency . Subjects receiving cannabis reported improved appetite and sleep, with no significant side effects.” http://www.ncbi.nlm.nih.gov/pubmed/23648372

Marijuana: Miracle Cure For Crohn’s Disease?

Posted on July 23, 2013 by David

“Crohn’s disease is a autoimmunity deficiency in the gastronomical tract that can cause anything from mild stomach pains to vomiting and in extreme cases, chronic bloody diarrhea. There’s no cure for the disorder but now, researchers in Israel say they’ve found evidence that marijuana causes complete remission of the disease.

This news comes the Meir Medical Center in Israel, which treated 21 patients suffering from Crohn’s disease. 11 of the patients smoked two joints per day of cannabis sativa, which the researchers believed would provide anti-inflammatory relief, while the other (unlucky) 10 were only given a placebo. “The marijuana plant Cannabis sativa has been reported to produce beneficial effects for patients with inflammatory bowel diseases, but this has not been investigated in controlled trials,” the researchers argued. “We performed a prospective trial to determine whether cannabis can induce remission in patients with Crohn’s disease.”

Five of the 11 patients who smoked the weed, the study, which was published in the U.S. National Library of Medicine, states, acheived “total remission” of their disease, whereas only four of the 10 patients who didn’t smoke the pot reported only slight improvement of their condition. Needless to say, the study, while promising, only seems to suggest that more research should be undertaken. “Further studies, with larger patient groups and a nonsmoking mode of intake, are warranted,” the scientists argued.”

http://blogs.ocweekly.com/navelgazing/2013/07/marijuana_miracle_cure_for_cro.php

[Marihuana and cannobinoids as medicaments].

Posted on July 23, 2013 by David

“Biological activity of cannabinoids is caused by binding to two cannabinoid receptors CB1 and CB2. Psychoactive is not only tetrahydrocannabinol (THC) but also: cannabidiol, cannabigerol or cannabichromen.

Formerly, the usefulness of hemp was assessed in the relation to temporary appeasement of the symptoms of some ailments as nausea or vomiting.

Present discoveries indicates that cannabis-based drugs has shown ability to alleviate of autoimmunological disorders such as: Multiple sclerosis (MS), Rheumatoid arthritis (RA) or inflammatory bowel disease.

Another studies indicates that cannabinoids play role in treatment of neurological disorders like Alzheimer disease or Amyotrophic lateral sclerosis (ALS) or even can reduce spreading of tumor cells.

Cannabinoids stand out high safety profile considering acute toxicity, it is low possibility of deadly overdosing and side-effects are comprise in range of tolerated side-effects of other medications.

In some countries marinol and nabilone are used as anti vomiting and nausea drug. First cannabis-based drug containg naturally occurring cannabinoids is Sativex. Sativex is delivered in an mucosal spray for patients suffering from spasticity in MS, pain relevant with cancer and neuropathic pain of various origin.

Cannabis side-effects varies and depend from several factors like administrated dose, rout of administration and present state of mind. After sudden break from long-lasting use, withdrawal symptoms can appear, although they entirely disappear after a week or two.”

http://www.ncbi.nlm.nih.gov/pubmed/23421098

Acute Δ9-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.

Posted on June 19, 2013 by David

“Nonsteroidal anti-inflammatory drugs (NSAIDs), which are among the most widely used analgesics in the world, cause gastrointestinal inflammation that is potentially life-threatening.

Although inhibitors of endocannabinoid catabolic enzymes protect against gastropathy in fasted NSAID-treated mice, the gastroprotective effects of Δ⁹-tetrahydrocannabinol (THC), the primary psychoactive component of marijuana, have yet to be investigated…

These data indicate that the phytocannabinoid Δ⁹-THC protects against diclofenac-induced gastric inflammatory tissue damage at doses insufficient to cause common cannabinoid side effects.”

http://www.ncbi.nlm.nih.gov/pubmed/23769745

Cannabidiol (CBD): Fighting Inflammation & Aggressive Forms of Cancer

Posted on June 7, 2013 by David

“Marijuana contains at least 60 known chemicals called cannabinoids, which activate cannabinoid receptors in your body. Tetrahydrocannabinol, or THC, is the main component responsible for the psychoactive effects, or “high,” marijuana is known for. While THC is known to have some medicinal value, there has been recent investigation into a new cannabinoid that is rumored to have more medicinal benefits than any single pharmaceutical drug on the market.”

“What is Cannabidiol (CBD)?

This cannabinoid is known as Cannabidiol (CBD), and is the second most abundant cannabinoid in cannabis. Research done by G.W. Pharmaceuticals suggests that CBD could be used for treating symptoms of rheumatoid arthritis and other autoimmune diseases, diabetes, nausea, bowel disorders, and many other hard-to-control side effects. According to an article from Projectcbd.com, CBD has even demonstrated neuroprotective effects, and its anti-cancer potential is currently being explored.

While it was originally believed that THC is a breakdown product of CBD, it is now known that both THC and CBD are actually metabolites of their decarboxylated acidic forms, THCa and CBDa. These acidic precursors are decarboxylated (essentially dried) by heat or extraction to produce THC and CBD; only then do they become psychoactive. The compound has medicinal benefits without the “high” that some patients do not desire. This makes CBD appealing to patients who are looking for an alternative to their current meds, which often have opiate-like effects.”

More: http://www.medicaljane.com/2012/12/20/cannabidiol-cbd-medicine-of-the-future/

The endocannabinoid system and its therapeutic exploitation.

Posted on May 24, 2013 by David

Image result for Nat Rev Drug Discov.

“The term ‘endocannabinoid’ – originally coined in the mid-1990s after the discovery of membrane receptors for the psychoactive principle in Cannabis, Delta9-tetrahydrocannabinol and their endogenous ligands – now indicates a whole signalling system that comprises cannabinoid receptors, endogenous ligands and enzymes for ligand biosynthesis and inactivation. This system seems to be involved in an ever-increasing number of pathological conditions. With novel products already being aimed at the pharmaceutical market little more than a decade since the discovery of cannabinoid receptors, the endocannabinoid system seems to hold even more promise for the future development of therapeutic drugs. We explore the conditions under which the potential of targeting the endocannabinoid system might be realized in the years to come.” http://www.ncbi.nlm.nih.gov/pubmed/15340387

http://www.nature.com/nrd/journal/v3/n9/full/nrd1495.html

Marijuana might be able to treat your terrible case of the runs – MSN

Posted on May 23, 2013 by David

“Seems there’s no end to the list of maladies medical marijuana can’t treat.”

“The latest: diarrhea, the awful affliction that sounds like “dire rear” for a reason. According to the pot aficionados behind The Weed Blog (who mightn’t be the most unbiased sources on the matter), cannabis-derived products have been used to treat diarrhea in India since at least the late 1800s. These products reportedly cause diarrhea and its symptoms to subside, and — surprise, surprise — help patients regain their appetites. Around 3.5 million people die from diarrhea and its nasty effects every year, so these alleged benefits of pot aren’t just useful to stoners who could fake the runs to score a medical marijuana prescription.”

http://now.msn.com/medical-marijuana-might-treat-diarrhea

Marijuana is an Effective Treatment for Crohn’s Disease